摘要
Psychosomatic disorders,characterized by significant contributions of psychosocial factors to the pathogenesis and progression of somatic organic diseases or functional impairments(e.g.,diabetes,essential hypertension,asthma,inflammatory bowel disease,and neurodermatitis),present unique diagnostic and therapeutic challenges[1].Traditional diagnostic frameworks,heavily reliant on clinicians’subjective judgment and limited by the qualitative nature of psychological assessments,often result in misdiagnosis or delayed detection.As a cornerstone of the Fourth Industrial Revolution,artificial intelligence(AI)has demonstrated transformative potential in medicine.In psychosomatic medicine,AI leverages advanced data analytics,machine learning,and natural language processing to decipher the intricate interplay between psychological and physiological mechanisms,offering novel tools for diagnosis,treatment,and prevention.However,its clinical integration raises critical ethical and operational concerns that warrant rigorous examination.
